reports
Coty Inc. to Present at Upcoming Investor Events
NEW YORK--(BUSINESS WIRE)-- Coty Inc. (NYSE: COTY) (Paris: COTY), one of the world’s largest beauty companies, announced that its company executives will present at upcoming investor events. Wednesday, June 5: Deutsche Bank Global Consumer Conference – Sue Nabi, Chief Executive Officer and Laurent Mercier, Chief Financial Officer, will present at 10:30 am CET in Paris, France. A webcast of the presentation and fireside chat will be available in the “Events & Presentations” section at . Thursday, June 13: Evercore ISI Virtual Consumer & Retail Conference – Sue Nabi, Chief Executive Offic...
Coty Inc. Prices €500 Million of Senior Secured Notes
NEW YORK--(BUSINESS WIRE)-- Regulatory News: Coty Inc. (NYSE:COTY) (Paris:COTY) (“Coty”), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, today announced the pricing of €500 million aggregate principal amount of 4.500% Senior Secured Notes due 2027 (the “Notes”) issued by Coty and its wholly-owned subsidiaries, HFC Prestige Products, Inc. and HFC Prestige International U.S. LLC (the “Co-Issuers” and collectively with Coty, the “Issuers”) in a private offering. Coty will receive gross proceeds of €500 mil...
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced The...
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis Topline data from Phase 2b trial of Descartes-08 in myasthenia gravis remains on track for mid-2024 GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Regenerative Medicine Advanced Therapy (“RMAT”) designatio...
Moody's Ratings assigns a Ba2 rating to Coty's new senior secured note...
Moody's Ratings (Moody's) assigned a Ba2 rating to Coty, Inc.'s ("Coty") new senior secured notes. All other ratings including the company's Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating (PDR), Ba2 senior secured revolver and notes ratings, B1 senior unsecured note ratings ...
Coty Inc. to Offer Senior Secured Notes
NEW YORK--(BUSINESS WIRE)-- Regulatory News: Coty Inc. (NYSE: COTY) (Paris: COTY)(“Coty”), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, today announced that it, together with its wholly-owned subsidiaries, HFC Prestige Products, Inc. and HFC Prestige International U.S. LLC (the “Co-Issuers” and collectively with Coty, the “Issuers”), launched an offering of €500 million aggregate principal amount of senior secured notes (the “Notes”), subject to market and customary conditions. The interest rates and ...
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annua...
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ GAITHERSBURG, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that management will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference on Monday, May 20, 2024, at 3:00 p.m. ET. A live webcast of the fireside chat is expected to be accessible in the Events section of the Company’...
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SAIA SAIA INC.
RYI RYERSON HOLDING CORPORATION
RM REGIONAL MANAGEMENT CORP
RHP RYMAN HOSPITALITY PROPERTIES INC.
PENN PENN NATIONAL GAMING INC.
LTRX LANTRONIX INC.
KMPR KEMPER CORPORATION
HUBB HUBBELL INCORPORATED CLASS B
HOO HERBALIFE NUTRITION LTD.
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CNMD CONMED CORPORATION
AXS AXIS CAPITAL HOLDINGS LIMITED
AMH AMERICAN HOMES 4 RENT CLASS A
AIN ALBANY INTERNATIONAL CORP. CLASS A
HWBK HAWTHORN BANCSHARES
EFR ENERGY FUELS
SABR SABRE CORP.
ALPN ALPINE SELECT AG
HTLD HEARTLAND EXPRESS INC.
MAC MACERICH COMPANY
HI HILLENBRAND INC.
GLO CLOUGH GLOBAL OPPORTUNITIES FUND
WDFC WD-40 COMPANY
PK PARK HOTELS & RESORTS INC.
CRVS CORVUS PHARMACEUTICALS
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
EAF GRAFTECH INTERNATIONAL
FRAF FRANKLIN FINANCIAL SERVICES CO.
BBDC BARINGS BDC INC.
GH GUARDANT HEALTH
MCFT MASTERCRAFT BOAT HOLDINGS
HQL TEKLA LIFE SCIENCES INVESTORS
CZR CAESARS ENTERTAINMENT INC
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
PSTV PLUS THERAPEUTICS INC
CTOS CUSTOM TRUCK ONE SOURCE
TBBK INC.
MEGI THE BANCORP
NPCT INC.
RXO_w MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
BYON NUVEEN CORE PLUS IMPACT FD
VSTS_w RXO INC
NBBK BEYON 3D LTD
ASGI VESTIS CORPORATION
EYPT NB BANCORP INC.
DBD ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
EYEPOINT PHARMACEUTICALS
INC.
DIEBOLD NIXDORF INCORPORATED
Kemper Corporation: 1 director
A director at Kemper Corporation bought 5,000 shares at 61.010USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
- Jonathan Moreland
KMPR KEMPER CORPORATION
HOO HERBALIFE NUTRITION LTD.
CNMD CONMED CORPORATION
SABR SABRE CORP.
ALPN ALPINE SELECT AG
MAC MACERICH COMPANY
WDFC WD-40 COMPANY
PK PARK HOTELS & RESORTS INC.
EAF GRAFTECH INTERNATIONAL
BBDC BARINGS BDC INC.
MCFT MASTERCRAFT BOAT HOLDINGS
HQL TEKLA LIFE SCIENCES INVESTORS
PSTV PLUS THERAPEUTICS INC
CTOS CUSTOM TRUCK ONE SOURCE
NPCT INC.
BYON NUVEEN CORE PLUS IMPACT FD
VSTS_w BEYON 3D LTD
ASGI VESTIS CORPORATION
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
Cartesian Therapeutics Reports First Quarter 2024 Financial Results an...
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update Topline data from Phase 2b trial of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy, in myasthenia gravis on track for mid-2024 On track to dose first patient in Phase 2 trial of Descartes-08 in SLE in 2Q24, as well as Phase 2 basket studies in additional autoimmune indications in 2H24 New headquarters expected to support scale of wholly owned, in-house cGMP manufacturing capabilities for clinical and commercial supply of Com...
Coty and Lena Gercke Embark on New License Agreement
NEW YORK--(BUSINESS WIRE)-- Today, Coty Inc. (NYSE:COTY) (Paris:COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, skin and body care, is pleased to announce that it has signed a long term license agreement with Lena Gercke to develop, produce, and distribute LeGer’s debut fragrance. This agreement marks the beginning of a long-term partnership between Coty and German Television Presenter and Model, Lena Gercke. The agreement is rooted in a mutual focus on empowerment, inspiration, and innovation. The collaboration comes as...
Coty Reports Strong Results Ahead of Beauty Market, with Double-Digit ...
NEW YORK--(BUSINESS WIRE)-- Coty Inc. (NYSE: COTY) (Paris:COTY) ("Coty" or "the Company") today announced its results for the third quarter of fiscal year 2024, ended March 31, 2024. The Company's strong above-market sales growth, reported and adjusted operating income growth, and reported and adjusted gross and operating margin expansion in Q3 solidifies nearly four years of Coty reporting results in-line to ahead of expectations. In 3Q24, Coty's net revenues grew 8% on a reported basis and 10% on a LFL basis, with reported and LFL results supported by growth in fragrances, color cosmetics,...
Citizens Community Bancorp, Inc. Reports First Quarter 2024 Earnings o...
Citizens Community Bancorp, Inc. Reports First Quarter 2024 Earnings of $0.39 Per Share; Nonperforming Assets Decreased 31%; Criticized Assets Decreased 25% EAU CLAIRE, Wis., April 29, 2024 (GLOBE NEWSWIRE) -- Citizens Community Bancorp, Inc. (the “Company”) (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the “Bank” or “CCFBank”), today reported earnings of $4.1 million and earnings per diluted share of $0.39 for the first quarter ended March 31, 2024, compared to $3.7 million and $0.35 per diluted share for the fourth quarter ended December 31, 2023, and $3.7 milli...
Cartesian Therapeutics Announces Approval of Conversion of Series A Co...
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split Proposals approved at Company’s special meeting of stockholders held March 27, 2024 GAITHERSBURG, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced results from a special meeting of stockholders held March 27, 2024. During the meeting, Cartesian stockholders approved the issuance of shares of co...
Coty remporte le prix Euronext de la meilleure introduction en bourse ...
PARIS--(BUSINESS WIRE)-- Coty (NYSE: COTY) (Paris: COTY), l'un des plus grands acteurs mondiaux du secteur de la beauté, avec un portefeuille de marques emblématiques de parfums, de maquillage et de soins, a remporté le prix Euronext 2024 de la meilleure introduction en bourse dans la catégorie Large Cap lors de la 12e conférence annuelle d'Euronext qui s'est tenue le 19 mars 2024 à Paris. Ce prix récompense le succès de l'introduction en bourse de Coty, la plus importante à ce jour sur Euronext Growth®. La double cotation sur Euronext Paris a été un franc succès pour l'entreprise, levant 33...
Coty Wins this year’s Euronext Best listing Award in the Large Cap cat...
PARIS--(BUSINESS WIRE)-- Coty (NYSE: COTY) (Paris: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, skin and body care, has won this year’s Euronext Best Listing Award in the Large Cap category, at the 12th edition of the Euronext Annual Conference held on March 19, 2024 in Paris. The award recognizes the success of Coty's global offering, the largest to date on Euronext Growth®. The secondary listing on Euronext Paris was a resounding success for the company, raising €339.2 million, making it the 47th listing on Euronext...
Cartesian Therapeutics Reports Full Year 2023 Financial Results and Pr...
Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy, in myasthenia gravis (MG) remains on track for mid-2024 On track to initiate Phase 2 study of Descartes-08 in systemic lupus erythematosus (SLE) in 1H24 as well as Phase 2 basket studies in additional autoimmune indications in 2H24 Following recent IND clearance, planning underway for first-in-human Phase 1 dose escalation study of Descartes-15, a next-generation mRNA CAR-T product ca...
Coty Inc: 1 director
A director at Coty Inc sold 159,982 shares at 12.609USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.